ONT has been the topic of a number of other reports. Berenberg Bank reaffirmed a “buy” rating and set a GBX 529 ($6.50) target price on shares of Oxford Nanopore Technologies in a research note on Tuesday, August 1st. Royal Bank of Canada reduced their target price on shares of Oxford Nanopore Technologies from GBX 350 ($4.30) to GBX 300 ($3.68) and set an “outperform” rating on the stock in a research note on Monday, November 13th. Finally, Barclays reissued an “overweight” rating and set a GBX 355 ($4.36) target price on shares of Oxford Nanopore Technologies in a research note on Thursday, September 7th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Oxford Nanopore Technologies has a consensus rating of “Buy” and a consensus price target of GBX 392.80 ($4.82).
Oxford Nanopore Technologies Stock Performance
About Oxford Nanopore Technologies
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
- Five stocks we like better than Oxford Nanopore Technologies
- What is the Dow Jones Industrial Average (DJIA)?
- 3 large caps with red hot RSIs with upside
- How to Invest in Electric Cars
- Johnson Controls International: Nothing but upside for investors
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Unity Software’s resilient rebound post-earnings setback
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.